Episode 466: VACCINE UPTAKE, LIABILITY, AND ALUMINUM IN VACCINES

Episode 466: VACCINE UPTAKE, LIABILITY, AND ALUMINUM IN VACCINES

From The Highwire with Del Bigtree by The Highwire with Del Bigtree

March 5, 2026 · 2h 2m

About this episode

The episode discusses vaccine uptake, liability issues, and the implications of aluminum in vaccines, featuring expert guests and breaking news on corporate accountability.

The HighWire with Del Bigtree — Episode 466 (March 5, 2026) opens with breaking legal and policy news: the Trump EPA has filed a brief at the U.S. Supreme Court backing Bayer/Monsanto and glyphosate (Roundup). Del breaks down what the government is arguing, what’s at stake for warning labels and litigation, and why the outcome could reshape corporate accountability around glyphosate-based herbicides. Then, Jefferey Jaxen covers the accelerating shift in public vaccine sentiment, as global vaccine uptake declines and pharmaceutical stocks react to falling demand. Del analyzes the latest reported data, including a major worldwide drop in Gardasil (HPV vaccine) uptake, and what these trends could signal for vaccine policy, mandates, and the future of the vaccine marketplace. Also, a dive into the growing national debate over vaccine manufacturer liability. New polling indicates strong public support for restoring legal accountability for vaccine makers, a key issue tied to vaccine injury protections, medical freedom, and federal vaccine policy. Plus, an in-studio scientific discussion you don’t want to miss: Del is joined by Dr. James Neuenschwander and Dr. Brian Hooker to break…

More episodes of The Highwire with Del Bigtree

Explore listener stats, chart rankings, contacts and more on the The Highwire with Del Bigtree podcast page.